Guidelines Call for More Transparency on Hepatitis C Drug Costs

Updated guidelines from the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America and the International Antiviral Society -USA attempt to provide an overview of hepatitis C virus treatments, including cost comparisons. Learn more here, login required. (Source: Medscape, 8/26/15)

You might also be interested in:

New Non-Profit Association Launches Free Guideline… January 16, 2019
NICE Report: Cancer Drugs Priced According to Effectiveness… February 25, 2019
Levinson: Robust, Long-Term Transparency in Health Care… November 20, 2018
PAI and BresMed Join Forces to Support Expanded Use of More… July 22, 2019
International Task Force Proposes Updated Definition of HTA March 26, 2019
Research Suggests Low-Cost Generics at High Risk of Shortages December 14, 2018
Pharmacy Benefit Managers: A Mechanism for Containing Costs or… October 1, 2018